Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 13, 2026, 8:46 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 544009 | NSE: BLUEJET

Blue Jet Healthcare Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 13, 2026, 8:46 am

Market Cap 6,546 Cr.
Current Price 377
Intrinsic Value₹430.85
High / Low 1,028/353
Stock P/E22.3
Book Value 72.4
Dividend Yield0.32 %
ROCE39.8 %
ROE30.2 %
Face Value 2.00
PEG Ratio2.21

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Blue Jet Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Blue Jet Healthcare Ltd 6,546 Cr. 377 1,028/35322.3 72.40.32 %39.8 %30.2 % 2.00
Shilpa Medicare Ltd 6,499 Cr. 332 502/26036.7 1250.15 %7.82 %4.21 % 1.00
Aarti Pharmalabs Ltd 6,152 Cr. 679 972/55728.5 2260.74 %17.4 %14.5 % 5.00
FDC Ltd 5,974 Cr. 367 528/33025.7 1491.36 %15.9 %11.8 % 1.00
Marksans Pharma Ltd 7,848 Cr. 173 271/15621.8 59.30.46 %20.0 %16.8 % 1.00
Industry Average20,618.65 Cr1,089.4655.17201.810.38%16.35%15.16%6.10

All Competitor Stocks of Blue Jet Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 169217180181167184163208318340355165192
Expenses 117147121119112131119139194200234111146
Operating Profit 52705963555344691241401215547
OPM % 31%32%33%35%33%29%27%33%39%41%34%33%24%
Other Income 6658-39912131282413
Interest 0000000000150
Depreciation 7666883555666
Profit before tax 51705864445449771321471236954
Tax % 27%27%24%26%27%27%24%24%25%25%26%24%25%
Net Profit 385144483240385899110915240
EPS in Rs 2.162.922.542.761.852.292.183.365.716.355.263.012.32

Last Updated: March 3, 2026, 11:42 am

Below is a detailed analysis of the quarterly data for Blue Jet Healthcare Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 165.00 Cr. (Sep 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
  • For Expenses, as of Dec 2025, the value is 146.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 111.00 Cr. (Sep 2025) to 146.00 Cr., marking an increase of 35.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Sep 2025) to 47.00 Cr., marking a decrease of 8.00 Cr..
  • For OPM %, as of Dec 2025, the value is 24.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Sep 2025) to 24.00%, marking a decrease of 9.00%.
  • For Other Income, as of Dec 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Sep 2025) to 13.00 Cr., marking a decrease of 11.00 Cr..
  • For Interest, as of Dec 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 5.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 6.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Sep 2025) to 54.00 Cr., marking a decrease of 15.00 Cr..
  • For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Sep 2025) to 25.00%, marking an increase of 1.00%.
  • For Net Profit, as of Dec 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Sep 2025) to 40.00 Cr., marking a decrease of 12.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 2.32. The value appears to be declining and may need further review. It has decreased from 3.01 (Sep 2025) to 2.32, marking a decrease of 0.69.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 1:50 am

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5384996837217121,0301,053
Expenses 325292434502481652690
Operating Profit 214207249219231378363
OPM % 40%41%36%30%32%37%34%
Other Income 691924184658
Interest 7531006
Depreciation 18202225281822
Profit before tax 194190243217220406393
Tax % 25%26%25%26%26%25%
Net Profit 145142182160164305294
EPS in Rs 24,118.331,428.7710.479.239.4417.5916.94
Dividend Payout % 0%0%0%0%11%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-2.07%28.17%-12.09%2.50%85.98%
Change in YoY Net Profit Growth (%)0.00%30.24%-40.26%14.59%83.48%

Blue Jet Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:14%
3 Years:15%
TTM:76%
Compounded Profit Growth
10 Years:%
5 Years:16%
3 Years:19%
TTM:118%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:48%
Return on Equity
10 Years:%
5 Years:31%
3 Years:27%
Last Year:31%

Last Updated: September 5, 2025, 2:45 pm

Balance Sheet

Last Updated: December 4, 2025, 2:33 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.60103535353535
Reserves 1983304876478111,0981,221
Borrowings 745219532121
Other Liabilities 92142173176211263251
Total Liabilities 3645347138621,0591,4181,527
Fixed Assets 107139156151172300303
CWIP 2333014789159
Investments 263794189250187210
Other Assets 229355460491489841855
Total Assets 3645347138621,0591,4181,527

Below is a detailed analysis of the balance sheet data for Blue Jet Healthcare Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
  • For Reserves, as of Sep 2025, the value is 1,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,098.00 Cr. (Mar 2025) to 1,221.00 Cr., marking an increase of 123.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 251.00 Cr.. The value appears to be improving (decreasing). It has decreased from 263.00 Cr. (Mar 2025) to 251.00 Cr., marking a decrease of 12.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 1,527.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,418.00 Cr. (Mar 2025) to 1,527.00 Cr., marking an increase of 109.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 303.00 Cr.. The value appears strong and on an upward trend. It has increased from 300.00 Cr. (Mar 2025) to 303.00 Cr., marking an increase of 3.00 Cr..
  • For CWIP, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 89.00 Cr. (Mar 2025) to 159.00 Cr., marking an increase of 70.00 Cr..
  • For Investments, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 187.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 23.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 855.00 Cr.. The value appears strong and on an upward trend. It has increased from 841.00 Cr. (Mar 2025) to 855.00 Cr., marking an increase of 14.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 1,527.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,418.00 Cr. (Mar 2025) to 1,527.00 Cr., marking an increase of 109.00 Cr..

Notably, the Reserves (1,221.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 12213714614224146
Cash from Investing Activity + -45-61-76-147-264-35
Cash from Financing Activity + -72-21-56-4-2-19
Net Cash Flow 55514-10-24-8

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow140.00155.00230.00214.00228.00357.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 8010512112191124
Inventory Days 120201133137151209
Days Payable 9010172583570
Cash Conversion Cycle 110204183199206262
Working Capital Days 5510510312092157
ROCE %58%53%35%30%40%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 86.00%86.00%86.00%86.00%86.00%86.00%86.00%79.81%79.81%
FIIs 2.93%2.01%2.02%2.18%1.10%2.28%1.97%1.83%1.14%
DIIs 3.70%3.04%2.14%1.75%2.02%1.33%0.95%3.63%4.65%
Public 7.37%8.97%9.83%10.06%10.87%10.38%11.08%14.74%14.41%
No. of Shareholders 55,58948,62542,88241,93343,00354,58170,77280,11780,187

Shareholding Pattern Chart

No. of Shareholders

Blue Jet Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 1,849,057 1.16 77.241,602,5432026-02-23 01:48:5315.38%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 21Mar 20
FaceValue 100.00100.00
Basic EPS (Rs.) 1396.271462.59
Diluted EPS (Rs.) 1396.271462.59
Cash EPS (Rs.) 1568.3027166.33
Book Value[Excl.RevalReserv]/Share (Rs.) 3428.3432238.33
Book Value[Incl.RevalReserv]/Share (Rs.) 3428.3432238.33
Revenue From Operations / Share (Rs.) 5033.6189699.16
PBDIT / Share (Rs.) 2168.4336589.16
PBIT / Share (Rs.) 1970.0533582.66
PBT / Share (Rs.) 1862.9632354.50
Net Profit / Share (Rs.) 1369.9224159.83
NP After MI And SOA / Share (Rs.) 1396.4324141.33
PBDIT Margin (%) 43.0740.79
PBIT Margin (%) 39.1337.43
PBT Margin (%) 37.0136.07
Net Profit Margin (%) 27.2126.93
NP After MI And SOA Margin (%) 27.7426.91
Return on Networth / Equity (%) 40.7375.40
Return on Capital Employeed (%) 52.3283.21
Return On Assets (%) 25.9438.58
Long Term Debt / Equity (X) 0.080.19
Total Debt / Equity (X) 0.100.30
Asset Turnover Ratio (%) 1.100.00
Current Ratio (X) 2.431.89
Quick Ratio (X) 1.691.37
Inventory Turnover Ratio (X) 2.300.00
Interest Coverage Ratio (X) 40.4929.79
Interest Coverage Ratio (Post Tax) (X) 27.5820.67

After reviewing the key financial ratios for Blue Jet Healthcare Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 21, the value is 100.00. This value exceeds the healthy maximum of 10. There is no change compared to the previous period (Mar 20) which recorded 100.00.
  • For Basic EPS (Rs.), as of Mar 21, the value is 1,396.27. This value is within the healthy range. It has decreased from 1,462.59 (Mar 20) to 1,396.27, marking a decrease of 66.32.
  • For Diluted EPS (Rs.), as of Mar 21, the value is 1,396.27. This value is within the healthy range. It has decreased from 1,462.59 (Mar 20) to 1,396.27, marking a decrease of 66.32.
  • For Cash EPS (Rs.), as of Mar 21, the value is 1,568.30. This value is within the healthy range. It has decreased from 27,166.33 (Mar 20) to 1,568.30, marking a decrease of 25,598.03.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 21, the value is 3,428.34. It has decreased from 32,238.33 (Mar 20) to 3,428.34, marking a decrease of 28,809.99.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 21, the value is 3,428.34. It has decreased from 32,238.33 (Mar 20) to 3,428.34, marking a decrease of 28,809.99.
  • For Revenue From Operations / Share (Rs.), as of Mar 21, the value is 5,033.61. It has decreased from 89,699.16 (Mar 20) to 5,033.61, marking a decrease of 84,665.55.
  • For PBDIT / Share (Rs.), as of Mar 21, the value is 2,168.43. This value is within the healthy range. It has decreased from 36,589.16 (Mar 20) to 2,168.43, marking a decrease of 34,420.73.
  • For PBIT / Share (Rs.), as of Mar 21, the value is 1,970.05. This value is within the healthy range. It has decreased from 33,582.66 (Mar 20) to 1,970.05, marking a decrease of 31,612.61.
  • For PBT / Share (Rs.), as of Mar 21, the value is 1,862.96. This value is within the healthy range. It has decreased from 32,354.50 (Mar 20) to 1,862.96, marking a decrease of 30,491.54.
  • For Net Profit / Share (Rs.), as of Mar 21, the value is 1,369.92. This value is within the healthy range. It has decreased from 24,159.83 (Mar 20) to 1,369.92, marking a decrease of 22,789.91.
  • For NP After MI And SOA / Share (Rs.), as of Mar 21, the value is 1,396.43. This value is within the healthy range. It has decreased from 24,141.33 (Mar 20) to 1,396.43, marking a decrease of 22,744.90.
  • For PBDIT Margin (%), as of Mar 21, the value is 43.07. This value is within the healthy range. It has increased from 40.79 (Mar 20) to 43.07, marking an increase of 2.28.
  • For PBIT Margin (%), as of Mar 21, the value is 39.13. This value exceeds the healthy maximum of 20. It has increased from 37.43 (Mar 20) to 39.13, marking an increase of 1.70.
  • For PBT Margin (%), as of Mar 21, the value is 37.01. This value is within the healthy range. It has increased from 36.07 (Mar 20) to 37.01, marking an increase of 0.94.
  • For Net Profit Margin (%), as of Mar 21, the value is 27.21. This value exceeds the healthy maximum of 10. It has increased from 26.93 (Mar 20) to 27.21, marking an increase of 0.28.
  • For NP After MI And SOA Margin (%), as of Mar 21, the value is 27.74. This value exceeds the healthy maximum of 20. It has increased from 26.91 (Mar 20) to 27.74, marking an increase of 0.83.
  • For Return on Networth / Equity (%), as of Mar 21, the value is 40.73. This value is within the healthy range. It has decreased from 75.40 (Mar 20) to 40.73, marking a decrease of 34.67.
  • For Return on Capital Employeed (%), as of Mar 21, the value is 52.32. This value is within the healthy range. It has decreased from 83.21 (Mar 20) to 52.32, marking a decrease of 30.89.
  • For Return On Assets (%), as of Mar 21, the value is 25.94. This value is within the healthy range. It has decreased from 38.58 (Mar 20) to 25.94, marking a decrease of 12.64.
  • For Long Term Debt / Equity (X), as of Mar 21, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 20) to 0.08, marking a decrease of 0.11.
  • For Total Debt / Equity (X), as of Mar 21, the value is 0.10. This value is within the healthy range. It has decreased from 0.30 (Mar 20) to 0.10, marking a decrease of 0.20.
  • For Asset Turnover Ratio (%), as of Mar 21, the value is 1.10. It has increased from 0.00 (Mar 20) to 1.10, marking an increase of 1.10.
  • For Current Ratio (X), as of Mar 21, the value is 2.43. This value is within the healthy range. It has increased from 1.89 (Mar 20) to 2.43, marking an increase of 0.54.
  • For Quick Ratio (X), as of Mar 21, the value is 1.69. This value is within the healthy range. It has increased from 1.37 (Mar 20) to 1.69, marking an increase of 0.32.
  • For Inventory Turnover Ratio (X), as of Mar 21, the value is 2.30. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 20) to 2.30, marking an increase of 2.30.
  • For Interest Coverage Ratio (X), as of Mar 21, the value is 40.49. This value is within the healthy range. It has increased from 29.79 (Mar 20) to 40.49, marking an increase of 10.70.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 21, the value is 27.58. This value is within the healthy range. It has increased from 20.67 (Mar 20) to 27.58, marking an increase of 6.91.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Blue Jet Healthcare Ltd as of March 15, 2026 is: ₹391.32

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 15, 2026, Blue Jet Healthcare Ltd is Undervalued by 3.80% compared to the current share price ₹377.00

Intrinsic Value of Blue Jet Healthcare Ltd as of March 15, 2026 is: ₹430.85

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 15, 2026, Blue Jet Healthcare Ltd is Undervalued by 14.28% compared to the current share price ₹377.00

Last 5 Year EPS CAGR: 10.10%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock is trading at a low valuation with an average P/B ratio of 17,776.36 and average Dividend Yield of 38.28%.
  2. The stock has a high average ROCE of 36.00%, which is a positive sign.
  3. The company has higher reserves (684.57 cr) compared to borrowings (27.86 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (450.71 cr) and profit (266.14 cr) over the years.
  1. The stock has a high average Working Capital Days of 105.33, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 194.00, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Blue Jet Healthcare Ltd:
    1. Net Profit Margin: 27.21%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 52.32% (Industry Average ROCE: 16.35%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 40.73% (Industry Average ROE: 15.16%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 27.58
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.69
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 22.3 (Industry average Stock P/E: 55.17)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.1
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Blue Jet Healthcare Ltd is a Public Limited Listed company incorporated on 07/12/1968 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1968PLC014154 and registration number is 014154. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 1029.99 Cr. and Equity Capital is Rs. 34.69 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals701, 702, 7th Floor, Navi Mumbai Maharashtra 400705Contact not found
Management
NamePosition Held
Mr. Akshay Bansarilal AroraExecutive Chairman
Mr. Shiven Akshay AroraManaging Director
Mr. Naresh Suryakant ShahExecutive Director
Mr. Popat B KedarExecutive Director
Ms. Divya Sameer MomayaIndependent Director
Mr. Girish Paman VanvariIndependent Director
Ms. Preeti Gautam MehtaIndependent Director
Ms. Priyanka YadavIndependent Director

FAQ

What is the intrinsic value of Blue Jet Healthcare Ltd?

Blue Jet Healthcare Ltd's intrinsic value (as of 15 March 2026) is ₹430.85 which is 14.28% higher the current market price of ₹377.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,546 Cr. market cap, FY2025-2026 high/low of ₹1,028/353, reserves of ₹1,221 Cr, and liabilities of ₹1,527 Cr.

What is the Market Cap of Blue Jet Healthcare Ltd?

The Market Cap of Blue Jet Healthcare Ltd is 6,546 Cr..

What is the current Stock Price of Blue Jet Healthcare Ltd as on 15 March 2026?

The current stock price of Blue Jet Healthcare Ltd as on 15 March 2026 is ₹377.

What is the High / Low of Blue Jet Healthcare Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Blue Jet Healthcare Ltd stocks is ₹1,028/353.

What is the Stock P/E of Blue Jet Healthcare Ltd?

The Stock P/E of Blue Jet Healthcare Ltd is 22.3.

What is the Book Value of Blue Jet Healthcare Ltd?

The Book Value of Blue Jet Healthcare Ltd is 72.4.

What is the Dividend Yield of Blue Jet Healthcare Ltd?

The Dividend Yield of Blue Jet Healthcare Ltd is 0.32 %.

What is the ROCE of Blue Jet Healthcare Ltd?

The ROCE of Blue Jet Healthcare Ltd is 39.8 %.

What is the ROE of Blue Jet Healthcare Ltd?

The ROE of Blue Jet Healthcare Ltd is 30.2 %.

What is the Face Value of Blue Jet Healthcare Ltd?

The Face Value of Blue Jet Healthcare Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Blue Jet Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports